NASDAQ:EARS
Delisted

Auris Medical Holding Ag Stock Signals

etoro logo Buy EARS
*Your capital is at risk
$0.750
-0.0010 (-0.133%)
At Close: May 27, 2022

Latest Data & Signals Issued

Below are some of the latest signals issued for Auris Medical Holding AG

General

Signal Type Signal Value Data
Score 0.000 61 days ( 17.58 %
Last Price $0.750 -0.133 %
Performance History
7 Days
$0.87 $0.750
-13.39%
30 Days
$0.94 $0.750
-20.21%
12 Mos
$3.49 $0.750
-78.51%

4/18

Active Buy Signals

Specific Signals

Short Term
Net score: 7.69
Signal Type Signal Value Importance Data
High / Low Neutral Very Low $0.740 - $0.82
Position: 12.66% from low / 87.34% from high · Momentum: -12.03%
Trend - 3 mos -8.85 % High Width: 187.83 %
Pred. range - 3 mos $0.506 - $1.46 Low -32.50 % - 94.29 %
Volume Direction Sell High Volume: 4 · Direction: 0
Pivot Short Sell Very Low May 20, 2022 - 6 days
RSI Short Pivot Signal Buy Very Low May 24, 2022 - 4 days
Short MA 3 mos Sell Low May 23, 2022 - 5 days
Long MA 3 mos Sell Medium Apr 18, 2022 - 30 days
Short/Long MA 3 mos Sell Medium Apr 22, 2022 - 26 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 31.5
Signal Type Signal Value Importance Data
Trend - 12 mos -69.65 % Very High Width: 623.67 %
Pred. range - 12 mos N/A - $0.392 High -100.00 % - -47.72 %
Short MA 12 mos Sell Very High May 23, 2022 - 5 days
Long MA 12 mos Buy Very High Apr 08, 2022 - 35 days
Short/Long MA 12 mos Sell Very High Jul 07, 2021 - 227 days
Pivot Long Sell Low May 20, 2022 - 6 days
RSI Long Pivot Signal Buy Low May 26, 2022 - 2 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Buy High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT AURIS MEDICAL HOLDING AG
Auris Medical Holding AG
Auris Medical Holding AG, a clinical-stage biopharmaceutical company, focuses on the development of novel products for the treatment of inner ear disorders. Its lead product candidate includes AM-101, which is in Phase III clinical development for treating acute inner ear tinnitus. The company is also developing AM-111 for the treatment of acute sensorineural hearing loss; and other pre-clinical stage products comprising AM-102 and AM-123. It has...
GOLDEN STAR
Ticker Change Signal Date
OSIS
$218.29
0.188% Jun 26
IIIV
$20.09
6.32% Jun 25
JLL
$299.78
3.39% Jun 24
NMRK
$15.02
0.599% Jun 24
X
XMAX
$8.34
8.99% Jun 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE